Cytokine expression in the gut associated lymphoid tissue after oral administration of attenuated Salmonella vaccine strains

Vaccine

Volumn 14, Issue 16, 1996, Pages 1495-1502

  Karem L, Kevin ^a   Kanangat, Sivadasan ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Cytokines; Gut associated lymphoid tissue (GALT); Salmonella vaccines

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; RECOMBINANT PROTEIN; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; IMMUNIZATION; INTESTINE LYMPHATIC TISSUE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PEYER PATCH; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; CYTOKINES; FEMALE; LYMPH NODES; MESENTERY; MICE; MICE, INBRED BALB C; PEYER'S PATCHES; SALMONELLA TYPHIMURIUM; TYPHOID-PARATYPHOID VACCINES; VACCINES, ATTENUATED;

EID: 0030294884     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00118-1     Document Type: Article

References (35)

1. 1 Staats, H.F., Jackson, R.J., Marinaro, M., Takahashi, I., Kiyono, H. and McGhee, J.R. Mucosal immunity to infection with implications for vaccine development. Curr. Opin. Immun. 1994, 6, 572-583
2. 2 McDermott, M.R. and Bienenstock, J. Evidence for a common mucosal immunologic system, I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues. J. Immun. 1979, 122, 1892-1898
3. 3 Mossmann, T.R. and Coffmann, R.L. TH1 and TH2 cells, different patterns of lymphokine secretion lead to different functional properties. A. Rev. Immun. 1989, 7, 145-173
4. 4 Coffmann, R.L., Varkila, K., Scott, P. and Chatelain, R. Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immun. Rev. 1991, 123, 189-207
5. 5 Chatfield, S.N., Dougan, G. and Roberts, M. Progress in the development of multivalent oral vaccines based on live attenuated Salmonella. In: Modern Vaccinology (Ed. Kurstak, E.). Plenum Medical, New York, 1994, pp. 55-86
6. 6 Roberts, M., Chatfield, S.N. and Dougan, G. Salmonella as carriers of heterologous antigens. In: Novel Delivery Systems for Oral Vaccines (Ed. O'Hagan, D.T.), CRC press, University of Tennessee, 1994, pp. 27-58
7. 7 Klimpel, G.R., Asancion, M., Haithcoat, J. and Niesel, D.W. Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract. Infect. Immun. 1995, 63, 1134-1137
8. 8 Brett, S.J., Dunlop, L. and Liew, F.Y. Influence of the antigen delivery system on immunoglobin isotype selection and cytokine production in response to influenza A nucleoprotein. Immunology 1993, 80, 306-312
9. 9 Challacombe, S.J. and Tomasi, T.B.Jr Systemic tolerance and secretory immunity after oral immunization. J. exp. Med. 1980, 152, 1459-1472
10. 10 Richman, L.K. Immunological unresponsiveness after enteric administration of protein antigens. In: Immunology of Breast Milk (Eds Ogra, P.L. and Dayton, D.). Raven Press, New York, 1979, pp. 49-62
11. 11 Chatfield, S.N., Charles, I.G., Makoff, A.J. et al. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains, Development of a single-dose oral tetanus vaccine. Bio/Technology 1992, 10, 888-892
12. 12 Bost, K.L. and Clements, J.D. In vivo induction of interleukin-12 mRNA expression after oral immunization with Salmonella dublin or the B subunit of Escherichia coli heat labile enterotoxin. Infect. Immun. 1995, 63, 1076-1083
13. 13 Jackson, R.J., Staats, H.F., Xu-Amano, J. et al. Oral vaccine models, multiple delivery systems employing tetanus toxoid. Ann. N.Y. Acad. Sci. 1994, 730, 217-234
14. 14 LeClerc, C., Lo-Man, R., Fayolle, C. et al. Molecular and cellular parameters controlling the immunogenicity of foriegn B-or T-cell epitopes expressed by recombinant vectors. Dev. biol. Stand. 1994, 82, 193-199
15. 15 VanCott, J.L., Staats, H.F., Pascual, D.W. et al. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella. J. Immun. 1996, 156, 1504-1514
16. 16 Nakayama, K., Kelly, S.M. and Curtiss, R.III Construction of an asd+ expression-cloning vector, stable maintenance and high level expression of cloned genes in a Salmonella vaccine strain. Bio Technology 1988, 6, 693-697
17. 17 Curtiss, R.III and Kelly, S.M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 1987, 55, 3035-3043
18. 18 Karem, K.L., Chatfield, S., Kuklin, N. and Rouse, B.T. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after a single mucosal or intravenous immunization of BALB/c mice. Infect. Immun. 1995, 63, 4557-4563
19. 19 Hoiseth, S.K. and Stocker, B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 1981, 291, 238-239
20. 20 Strugnell, R., Dougan, G., Chatfield, S. et al. Characterization of a Salmonella typhimurium aro vaccine strain expressing the P.69 antigen of Bordetella pertussis. Infect. Immun. 1992, 60, 3394-4002
21. 21 Kanangat, S., Solomon, A. and Rouse, B.T. Use of quantitative polymerase chain reaction to quantitate cytokine messenger RNA molecules. Molec. Immun. 1992, 29, 1229-1236
22. 22 Babu, J.S., Kanangat, S. and Rouse, B.T. Limitations an modifications of quantitative polymerase chain reaction. J. Immun. Meth. 1993, 165, 207-21619
23. 23 Coutelier, J.P., VanDer Logt, J.T.M., Heessen, F.W.A., Vinnk, A. and VanSnick, J. Virally induced modulation of murine IgG antibody subclasses. J. exp. Med. 1988, 168, 2372-2378
24. 24 Yamamura, M., Uyemura, K., Deans, R.J. et al. Defining protective responses to pathogens, cytokine profiles in leprosy lesions. Science 1991, 254, 277-279
25. 25 Kuklin, N., Karem, K.L., Kanangat, S. and Rouse, B.T. Characterization of mucosal and systemic immune responses to orally administered Herpes Simplex Virus type-1 in BALB/c mice, requirements for protection against mucosal challenge, 1995 (in preparation)
26. 26 Becky Kelly, E.A., Cruz, E.S., Handa, K.M. and Wasson, D.L. IFN-γ and IL-5 producing cells compartmentalize to different lymphoid organs in Trichinella spiralis infected mice. J. Immun. 1991, 147, 306-311
27. 27 Maloy, K.J., Donachie, A.M. and Mowat, A.M. Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS. Eur. J. Immun. 1995, 25, 2835-2841
28. 28 Watanabe, M., Ueno, Y., Yajima, T. et al. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J. clin. Invest. 1995, 95, 2945-2953
29. 29 Komschlies, K.L., Grzegorzewski, K.J. and Wiltrout, R.H. Diverse immunological and hematological effects of interleukin 7, implications for clinical application. J. Leuk. Biol. 1995, 58, 623-633
30. 30 Okada, M., Kitahara, M., Kishimoto, S., Matsuda, T., Hirano, T. and Kishimoto, T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J. Immun. 1988, 141, 1543
31. 31 Quentmeier, H., Klancke, J., Muhlaradt, R.F. and Drexler, H.G. Role of IL-6, IL-2 and IL-4 in the in vitro induction of cytotoxic T cells. J. Immun. 1992, 149, 3316-3320
32. 32 Xu-Amano, B.J., Kiyono, H., Jackson, R.J. et al. Helper T cell subsets for immunoglobulin A responses, oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. exp. Med. 1993, 178, 1309-1320
33. 33 Hedges, S.R., Agace, W.W. and Svanburg, C. Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol. 1995, 3, 266-270
34. 34 Denich, K., Börlin, P., O'Hanley, P.D., Howard, M. and Heath, A.W. Expression of the murine interleukin-4 gene in an attenuated aroA strain of Salmonella typhimurium, persistence and immune response in BALB/c mice and susceptibility to macrophage killing. Infect. Immun. 1993, 61, 4818-4827
35. 35 Ianaro, A., Zu, D., O'Donnell, C.A., Rosa, M.D. and Liew, F.Y. Expression of TGF-beta in attenuated Salmonella typhimurium, oral administration leads to the reduction of inflammation, IL-2 and IFN-gamma, but enhancement of IL-10, in carrageenin-induced oedema in mice. Immunology 1995, 84, 5-15